GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (OTCPK:MBXBF) » Definitions » Days Sales Outstanding

Microbix Biosystems (Microbix Biosystems) Days Sales Outstanding : 42.83 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Microbix Biosystems Days Sales Outstanding?

Microbix Biosystems's average Accounts Receivable for the three months ended in Dec. 2023 was $2.94 Mil. Microbix Biosystems's Revenue for the three months ended in Dec. 2023 was $6.27 Mil. Hence, Microbix Biosystems's Days Sales Outstanding for the three months ended in Dec. 2023 was 42.83.

The historical rank and industry rank for Microbix Biosystems's Days Sales Outstanding or its related term are showing as below:

MBXBF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.66   Med: 65.69   Max: 79.32
Current: 56.13

During the past 13 years, Microbix Biosystems's highest Days Sales Outstanding was 79.32. The lowest was 38.66. And the median was 65.69.

MBXBF's Days Sales Outstanding is ranked better than
64.05% of 893 companies
in the Biotechnology industry
Industry Median: 73.34 vs MBXBF: 56.13

Microbix Biosystems's Days Sales Outstanding declined from Dec. 2022 (108.54) to Dec. 2023 (42.83).


Microbix Biosystems Days Sales Outstanding Historical Data

The historical data trend for Microbix Biosystems's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Days Sales Outstanding Chart

Microbix Biosystems Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.40 62.17 58.63 71.31 79.82

Microbix Biosystems Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108.54 64.75 52.67 80.56 42.83

Competitive Comparison of Microbix Biosystems's Days Sales Outstanding

For the Biotechnology subindustry, Microbix Biosystems's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbix Biosystems's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Microbix Biosystems's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Microbix Biosystems's Days Sales Outstanding falls into.



Microbix Biosystems Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Microbix Biosystems's Days Sales Outstanding for the fiscal year that ended in Sep. 2023 is calculated as

Days Sales Outstanding (A: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2022 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (2.293 + 3.045) / 2 ) / 12.205*365
=2.669 / 12.205*365
=79.82

Microbix Biosystems's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (3.045 + 2.838) / 2 ) / 6.267*365 / 4
=2.9415 / 6.267*365 / 4
=42.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Microbix Biosystems  (OTCPK:MBXBF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Microbix Biosystems Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbix Biosystems (Microbix Biosystems) Business Description

Traded in Other Exchanges
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.

Microbix Biosystems (Microbix Biosystems) Headlines

From GuruFocus

Microbix Announces Annual and Special Meeting Voting Results

By GlobeNewswire GlobeNewswire 04-01-2020

Microbix Attains Health Canada Establishment Licensing

By GlobeNewswire GlobeNewswire 04-21-2020

Microbix Announces Extension of Warrant Expiry Date

By GlobeNewswire GlobeNewswire 05-18-2023